858597-92-9 Usage
Chemical Structure
A ketone derivative containing a pyridine ring and a benzyl group
Functional Groups
Ketone, pyridine ring, benzyl group
Applications
a. Intermediate in the synthesis of pharmaceuticals and agrochemicals
b. Versatile building block in organic synthesis due to the presence of the benzyl group
c. Research and development for potential pharmacological properties
Properties
a. Easy functionalization and modification due to the benzyl group
b. Potential to act as an inhibitor of certain enzymes or receptors
Uses
a. In the development of new drugs and agrochemicals
b. As a starting material for the synthesis of more complex organic compounds
c. In the study of enzyme or receptor inhibition for therapeutic purposes
Check Digit Verification of cas no
The CAS Registry Mumber 858597-92-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,5,9 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 858597-92:
(8*8)+(7*5)+(6*8)+(5*5)+(4*9)+(3*7)+(2*9)+(1*2)=249
249 % 10 = 9
So 858597-92-9 is a valid CAS Registry Number.
858597-92-9Relevant articles and documents
HETEROARYL SUBSTITUTED BETA-HYDROXYETHYLAMINES FOR USE IN TREATING HYPERGLYCAEMIA
-
Page/Page column 61, (2019/04/11)
There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof,wherein the ring containing Q1to Q5, and the groups R1, R2 and R3, have meanings as provided in the description.
PYRROLIDINONE DERIVATIVES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
-
Page/Page column 68, (2014/05/07)
The present invention relates to pyrrolidinone derivatives of formula (I). The pyrrolidinone derivatives of formula (I) are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of pyrrolidinone derivatives as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
